- Investing Ideas
- /
- Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Norwegian Pharmaceuticals & Biotech Top Stock Picks from Analysts
Results
5
Companies which are more than 50% undervalued based on analyst price target.
5 companies
Photocure
Market Cap: NOK 1.4b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products in the Nordic countries, Germany, France, Austria, the United Kingdom, the Benelux, Italy, rest of the Europe, Canada, and the United States.
PHO
NOK 54.20
7D
6.1%
1Y
0.6%
Nykode Therapeutics
Market Cap: NOK 785.7m
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies.
NYKD
NOK 2.41
7D
14.6%
1Y
-80.8%
Navamedic
Market Cap: NOK 342.7m
A pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Norway, Sweden, Denmark, Finland, the Netherlands, and internationally.
NAVA
NOK 19.40
7D
1.3%
1Y
-42.1%
Lytix Biopharma
Market Cap: NOK 341.3m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 5.00
7D
2.7%
1Y
-9.1%
Circio Holding
Market Cap: NOK 53.1m
A biotechnology company, develops novel circular RNA and immunotherapy medicines.
CRNA
NOK 0.65
7D
16.9%
1Y
-76.8%